Skip to main content
OMCL
NASDAQ Technology

Omnicell Reports Strong Q1 Results, Returns to GAAP Profitability, and Raises Full-Year Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$39.49
Mkt Cap
$1.711B
52W Low
$22.66
52W High
$55
52W Position info
74% above low
Off High info
28% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

OMCL sits 74% above its 52-week low of $22.66.

Summary

Omnicell announced robust first-quarter 2026 financial results, returning to GAAP profitability and significantly increasing non-GAAP earnings, leading to an upward revision of its full-year profitability guidance.


Key Events · Earnings and Guidance · OMCL

  • Strong Q1 2026 Financial Performance

    Total revenues for the first quarter of 2026 increased by 15% year-over-year to $310 million, driven by connected devices, technical services, SaaS, and consumables.

  • Return to GAAP Profitability

    The company reported GAAP net income of $11 million ($0.25 per diluted share) for Q1 2026, a significant improvement from a GAAP net loss of $7 million ($0.15 per diluted share) in Q1 2025.

  • Raised Full-Year 2026 Profitability Guidance

    Omnicell increased its full-year 2026 non-GAAP EBITDA guidance to $153 million - $168 million and non-GAAP earnings per share guidance to $1.80 - $2.00, citing strong Q1 performance and cost discipline.

  • Improved Cash Flow and Balance Sheet

    Cash and cash equivalents increased to $239 million as of March 31, 2026, from $196.5 million at year-end 2025, with cash flows provided by operating activities totaling $55 million for the quarter.


Analysis · OMCL · Technology

Omnicell delivered a strong first quarter, significantly improving its financial position compared to the prior year and the recent 2025 annual report which noted declines in net income and cash. The company returned to GAAP net income profitability and saw substantial increases in non-GAAP net income and EBITDA. Crucially, management raised its full-year 2026 guidance for non-GAAP EBITDA and non-GAAP EPS, signaling increased confidence in future performance and disciplined cost management. This positive update, coupled with improved operating cash flow and a stronger balance sheet, suggests a positive trajectory for the company following previous challenges.

At the time of this filing, OMCL was trading at $39.49 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $22.66 to $55.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OMCL - Latest Insights

OMCL
Jul 01, 2026, 8:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $41.66
Real-time Price: $43.05 info
Change: +$1.39 (+3%) info
Market Cap: $1.958B info
OMCL
May 26, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $44.10
Real-time Price: $43.05 info
Change: -$1.05 (-2%) info
Market Cap: $1.958B info
OMCL
May 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $43.76
Real-time Price: $43.05 info
Change: -$0.710 (-2%) info
Market Cap: $1.958B info
OMCL
Apr 13, 2026, 4:16 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $35.01
Real-time Price: $43.05 info
Change: +$8.04 (+23%) info
Market Cap: $1.958B info
OMCL
Apr 02, 2026, 4:15 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $34.15
Real-time Price: $43.05 info
Change: +$8.90 (+26%) info
Market Cap: $1.958B info